Author + information
Chin KM, Rubin LJ. Pulmonary Arterial Hypertension. J Am Coll Cardiol 2008;51:1527–38.
In Figure 2 of this article, the treatment algorithm for pulmonary arterial hypertension (PAH) adapted from the ACCP guidelines should have listed subcutaneous treprostinil for functional class III PAH as having received a level “B” rather than level “C” strength of recommendation. The corrected figure is printed below. The authors apologize for this error.
- American College of Cardiology Foundation